There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Argenx Se (NASDAQ: ARGX), Arena Pharma (NASDAQ: ARNA) and Syndax Pharmaceuticals Inc (NASDAQ: SNDX) with bullish sentiments.
Argenx Se (NASDAQ: ARGX)In a report released today, Boris Peaker from Cowen & Co. maintained a Buy rating on Argenx Se (NASDAQ: ARGX). The company’s shares opened today at $87.99, close to its 52-week high of $90.20.
According to TipRanks.com, Peaker is a 5-star analyst with an average return of 18.2% and a 52.3% success rate. Peaker covers the Healthcare sector, focusing on stocks such as Corvus Pharmaceuticals Inc, Stemline Therapeutics Inc, and Mersana Therapeutics Inc.
Currently, the analyst consensus on Argenx Se is Strong Buy and the average price target is $108.50, representing a 23.3% upside.In a report issued on April 26, Wedbush also maintained a Buy rating on the stock with a $92 price target.